Notice To Announce Request for Information on the Development of the National Institute of Diabetes and Digestive and Kidney Diseases Strategic Plan, 17090-17091 [2020-06271]
Download as PDF
17090
Federal Register / Vol. 85, No. 59 / Thursday, March 26, 2020 / Notices
• April 15, 2020 from approximately
9:30 a.m. to 2:30 p.m./Eastern Time
(virtual meeting)
• May 20, 2020 from approximately
9:30 a .m. to 2:30 p.m./Eastern Time
(virtual meeting)
Composition
• June 17, 2020 from approximately
9:30 a.m. to 2:30 p.m./Eastern Time
The HITAC is comprised of at least 25
(virtual meeting)
members, of which:
• September date TBD
D No fewer than 2 members are
advocates for patients or consumers • October 21, 2020 from approximately
9:30 a.m. to 2:30 p.m./Eastern Time
of health information technology;
(virtual meeting)
D 3 members are appointed by the HHS
• November 10, 2020 from
Secretary
approximately 9:30 a.m. to 2:30 p.m./
Æ 1 of whom shall be appointed to
Eastern Time (virtual meeting)
represent the Department of Health
All meetings are open to the public.
and Human Services and
Additional
meetings may be scheduled
Æ 1 of whom shall be a public health
as needed. For web conference
official;
instructions and the most up-to-date
D 2 members are appointed by the
information, please visit the HITAC
majority leader of the Senate;
calendar on the ONC website, https://
D 2 members are appointed by the
www.healthit.gov/topic/federalminority leader of the Senate;
advisory-committees/hitac-calendar.
D 2 members are appointed by the
Contact Person for Meetings: Lauren
Speaker of the House of
Richie, lauren.richie@hhs.gov. A notice
Representatives;
in the Federal Register about last
D 2 members are appointed by the
minute modifications that impact a
minority leader of the House of
previously announced advisory
Representatives; and
committee meeting cannot always be
D Other members are appointed by the
published quickly enough to provide
Comptroller General of the United
timely notice. Please email Lauren
States.
Richie for the most current information
Members will serve for one-, two-, or
about meetings.
three-year terms. All members may be
Agenda: As outlined in the 21st
reappointed for a subsequent three-year Century Cures Act, the HITAC will
develop and submit recommendations
term. Each member is limited to two
three-year terms, not to exceed six years to the National Coordinator on the
of service. After establishment, members topics of interoperability, privacy and
shall be appointed for a three-year term. security, and patient access. In addition,
Members serve without pay, but will be the committee will also address any
administrative matters and hear
provided per-diem and travel costs for
periodic reports from ONC. ONC
committee services.
intends to make background material
Recommendations
available to the public no later than 24
The HITAC recommendations to the
hours prior to the meeting start time. If
National Coordinator are publicly
ONC is unable to post the background
available at https://www.healthit.gov/
material on its website prior to the
topic/federal-advisory-committees/
meeting, the material will be made
recommendations-national-coordinator- publicly available at the location of the
health-it.
advisory committee meeting, and the
background material will be posted on
Public Meetings
ONC’s website after the meeting, at
The revised schedule of meetings to
https://www.healthit.gov/hitac.
be held in 2020 is as follows:
Procedure: Interested persons may
present data, information, or views,
• January 15, 2020 from approximately
9:30 a.m. to 2:30 p.m./Eastern Time at orally or in writing, on issues pending
before the committee. Written
the Washington Plaza Hotel, 10
submissions may be made to the contact
Thomas Circle NW, Washington, DC
person prior to the meeting date. An
20005
• February 19, 2020 from approximately oral public comment period will be
scheduled at each meeting. Time
9:30 a.m. to 2:30 p.m./Eastern Time
allotted for each presentation will be
(virtual meeting)
limited to three minutes. If the number
• March 18, 2020 from approximately
of speakers requesting to comment is
9:30 a.m. to 2:30 p.m./Eastern Time
greater than can be reasonably
(virtual meeting)
accommodated during the scheduled
• March 26, 2020 from approximately
public comment period, ONC will take
10:30 a.m. to 1:30 p.m./Eastern Time
written comments after the meeting.
(virtual meeting)
lotter on DSKBCFDHB2PROD with NOTICES
Committee Act (FACA) (Pub. L. 92–
463), as amended, (5 U.S.C. App.),
which sets forth standards for the
formation and use of federal advisory
committees.
VerDate Sep<11>2014
17:20 Mar 25, 2020
Jkt 250001
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
Persons attending ONC’s HITAC
meetings are advised that the agency is
not responsible for providing wireless
access or access to electrical outlets.
ONC welcomes the attendance of the
public at its HITAC meetings. Seating is
limited at the location, and ONC will
make every effort to accommodate
persons with physical disabilities or
special needs. If you require special
accommodations due to a disability,
please contact Lauren Richie at least
seven (7) days in advance of the
meeting.
Notice of these meetings are given
under the Federal Advisory Committee
Act (Pub. L. No. 92–463 , 5 U.S.C., App.
2).
Dated: March 19, 2020.
Lauren Richie,
Office of Policy, Office of the National
Coordinator for Health Information
Technology.
[FR Doc. 2020–06345 Filed 3–25–20; 8:45 am]
BILLING CODE 4150–45–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice To Announce Request for
Information on the Development of the
National Institute of Diabetes and
Digestive and Kidney Diseases
Strategic Plan
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Request for Information.
SUMMARY: This Request for Information
(RFI) is intended to gather broad public
input to assist the National Institute of
Diabetes and Digestive and Kidney
Diseases (NIDDK) in developing the
NIDDK Strategic Plan. NIDDK invites
input from: The scientific research
community; patients and caregivers;
health care providers and health
advocacy organizations; scientific and
professional organizations; federal
agencies; and other stakeholders,
including interested members of the
public. Organizations are strongly
encouraged to submit a single response
that reflects the views of their
organization and their membership as a
whole.
DATES: Comments must be received by
11:59:59 p.m. (ET) on May 18, 2020 to
ensure consideration.
ADDRESSES: All comments must be
submitted electronically on the
submission website, available at https://
grants.nih.gov/grants/rfi/rfi.cfm?ID=106.
FOR FURTHER INFORMATION CONTACT:
Please direct all inquiries to: Lisa
E:\FR\FM\26MRN1.SGM
26MRN1
Federal Register / Vol. 85, No. 59 / Thursday, March 26, 2020 / Notices
lotter on DSKBCFDHB2PROD with NOTICES
Gansheroff, NIDDKstrategicplan@
nih.gov, 301.496.6623.
SUPPLEMENTARY INFORMATION: In
accordance with the 21st Century Cures
Act, NIH is required to regularly update
their strategic plans. The National
Institute of Diabetes and Digestive and
Kidney Diseases (NIDDK) is embarking
on an Institute-wide strategic planning
process. The goal of the process is to
develop a broad vision for accelerating
research into the causes, prevention,
and treatment of diseases and
conditions within the Institute’s
mission. This overarching trans-NIDDK
Strategic Plan will complement
NIDDK’s disease-specific planning
efforts. The strategic plan will have a 5year time horizon but will also include
planning for longer term efforts that
could be initiated within this time
frame.
A critical component of this strategic
planning process is to seek input from
the research and patient communities
and others who have an interest in
research within the mission of NIDDK.
As part of that approach, the purpose of
this Request for Information (RFI) is to
invite input on opportunities and
strategies to advance NIDDK’s mission.
NIDDK will use responses collected as
part of this RFI to inform the
development of the Institute-wide
Strategic Plan, which will be posted in
draft form for additional public
comment.
NIDDK conducts and supports
biomedical research and research
training and disseminates science-based
information on: Diabetes and other
endocrine and metabolic diseases;
digestive diseases, including liver,
gastrointestinal, and other diseases;
nutritional disorders; obesity; and
kidney, urologic, and hematologic
diseases, to improve people’s health and
quality of life. Based on this mission,
NIDDK has formulated the following
broad themes for input, as a starting
point for the planning process:
Themes for Input
• Advancing understanding of
biological pathways and environmental
contributors to health and disease.
• Advancing progress in pivotal
clinical studies and trials for
prevention, treatment, and cures in
diverse populations.
• Advancing dissemination and
implementation research on strategies to
identify, adapt, scale-up, and integrate
evidence-based interventions in diverse
settings and populations.
• Promoting participant
engagement—including patients and
other participants as true partners in
research.
VerDate Sep<11>2014
17:20 Mar 25, 2020
Jkt 250001
• Advancing research training and
career development to promote a
talented, diverse biomedical research
workforce.
• Promoting innovation, rigor and
reproducibility in research,
partnerships, communicating research
results, and other critical efforts as part
of efficient and effective stewardship of
public resources.
NIDDK invites input from: The
scientific research community; patients
and caregivers; health care providers
and health advocacy organizations;
scientific and professional
organizations; federal agencies; and
other stakeholders, including interested
members of the public.
NIDDK seeks input on any of the
broad themes above. Your comments
could include any of the following:
Research opportunities for the themes
highlighted above; innovative strategies
to advance research progress; the
challenges to progress in these areas;
emerging trends, advances,
technologies, analytic strategies,
challenges in big data science, and
perspectives that NIDDK should
consider in this planning process;
potential approaches to gauge research
progress and success. Please also
comment on any other topic that you
find relevant to the development of the
NIDDK Institute-wide Strategic Plan.
Organizations are strongly encouraged
to submit a single response that reflects
the views of their organization and
membership as a whole.
Responses to this RFI are voluntary
and may be submitted anonymously.
Please do not include any information
that you do not wish to make public.
Proprietary, classified, confidential, or
sensitive information should not be
included in your response. The
Government will use the information
submitted in response to this RFI at its
discretion. Individual feedback will not
be provided to any responder. The
Government reserves the right to use
any submitted information on public
websites, in reports, in summaries of the
state of the science, in any possible
resultant solicitation(s), grant(s), or
cooperative agreement(s), or in the
development of future funding
opportunity announcements. This RFI is
for informational and planning purposes
only and is not a solicitation for
applications or an obligation on the part
of the Government to provide support
for any ideas identified in response to
it. Please note that the Government will
not pay for the preparation of any
information submitted or for use of that
information.
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
17091
NIDDK looks forward to your input
and we hope that you will share this RFI
with your colleagues.
Dated: March 20, 2020.
Bruce T. Roberts,
Health Science Policy Analyst, National
Institute of Diabetes and Digestive and Kidney
Diseases.
[FR Doc. 2020–06271 Filed 3–25–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
Postponement of the April 2020
Customs Broker’s License
Examination
U.S. Customs and Border
Protection, Department of Homeland
Security.
ACTION: General notice.
AGENCY:
SUMMARY: This document announces
that U.S. Customs and Border Protection
(CBP) has postponed the customs
broker’s license examination scheduled
for April 1, 2020. The examination is
postponed due to the unprecedented
situation related to the coronavirus
(COVID–19), which is having a
nationwide impact on CBP’s ability to
conduct the examination.
DATES: The customs broker’s license
examination scheduled for April 1, 2020
is postponed.
FOR FURTHER INFORMATION CONTACT:
Randy Mitchell, Director, Commercial
Operations, Revenue and Entry, Office
of Trade, (202) 325–6532, or
brokermanagement@cbp.dhs.gov.
SUPPLEMENTARY INFORMATION:
Background
Section 641 of the Tariff Act of 1930,
as amended (19 U.S.C. 1641), provides
that a person (an individual,
corporation, association, or partnership)
must hold a valid customs broker’s
license and permit in order to transact
customs business on behalf of others,
sets forth standards for the issuance of
brokers’ licenses and permits, and
provides for the taking of disciplinary
action against brokers that have engaged
in specified types of infractions. This
section also provides that an
examination may be conducted to assess
an applicant’s qualifications for a
license.
The regulations issued under the
authority of section 641 are set forth in
Title 19 of the Code of Federal
Regulations, part 111 (19 CFR part 111).
Part 111 sets forth the regulations
E:\FR\FM\26MRN1.SGM
26MRN1
Agencies
[Federal Register Volume 85, Number 59 (Thursday, March 26, 2020)]
[Notices]
[Pages 17090-17091]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-06271]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Notice To Announce Request for Information on the Development of
the National Institute of Diabetes and Digestive and Kidney Diseases
Strategic Plan
AGENCY: National Institutes of Health, HHS.
ACTION: Request for Information.
-----------------------------------------------------------------------
SUMMARY: This Request for Information (RFI) is intended to gather broad
public input to assist the National Institute of Diabetes and Digestive
and Kidney Diseases (NIDDK) in developing the NIDDK Strategic Plan.
NIDDK invites input from: The scientific research community; patients
and caregivers; health care providers and health advocacy
organizations; scientific and professional organizations; federal
agencies; and other stakeholders, including interested members of the
public. Organizations are strongly encouraged to submit a single
response that reflects the views of their organization and their
membership as a whole.
DATES: Comments must be received by 11:59:59 p.m. (ET) on May 18, 2020
to ensure consideration.
ADDRESSES: All comments must be submitted electronically on the
submission website, available at https://grants.nih.gov/grants/rfi/rfi.cfm?ID=106.
FOR FURTHER INFORMATION CONTACT: Please direct all inquiries to: Lisa
[[Page 17091]]
Gansheroff, [email protected], 301.496.6623.
SUPPLEMENTARY INFORMATION: In accordance with the 21st Century Cures
Act, NIH is required to regularly update their strategic plans. The
National Institute of Diabetes and Digestive and Kidney Diseases
(NIDDK) is embarking on an Institute-wide strategic planning process.
The goal of the process is to develop a broad vision for accelerating
research into the causes, prevention, and treatment of diseases and
conditions within the Institute's mission. This overarching trans-NIDDK
Strategic Plan will complement NIDDK's disease-specific planning
efforts. The strategic plan will have a 5-year time horizon but will
also include planning for longer term efforts that could be initiated
within this time frame.
A critical component of this strategic planning process is to seek
input from the research and patient communities and others who have an
interest in research within the mission of NIDDK. As part of that
approach, the purpose of this Request for Information (RFI) is to
invite input on opportunities and strategies to advance NIDDK's
mission.
NIDDK will use responses collected as part of this RFI to inform
the development of the Institute-wide Strategic Plan, which will be
posted in draft form for additional public comment.
NIDDK conducts and supports biomedical research and research
training and disseminates science-based information on: Diabetes and
other endocrine and metabolic diseases; digestive diseases, including
liver, gastrointestinal, and other diseases; nutritional disorders;
obesity; and kidney, urologic, and hematologic diseases, to improve
people's health and quality of life. Based on this mission, NIDDK has
formulated the following broad themes for input, as a starting point
for the planning process:
Themes for Input
Advancing understanding of biological pathways and
environmental contributors to health and disease.
Advancing progress in pivotal clinical studies and trials
for prevention, treatment, and cures in diverse populations.
Advancing dissemination and implementation research on
strategies to identify, adapt, scale-up, and integrate evidence-based
interventions in diverse settings and populations.
Promoting participant engagement--including patients and
other participants as true partners in research.
Advancing research training and career development to
promote a talented, diverse biomedical research workforce.
Promoting innovation, rigor and reproducibility in
research, partnerships, communicating research results, and other
critical efforts as part of efficient and effective stewardship of
public resources.
NIDDK invites input from: The scientific research community;
patients and caregivers; health care providers and health advocacy
organizations; scientific and professional organizations; federal
agencies; and other stakeholders, including interested members of the
public.
NIDDK seeks input on any of the broad themes above. Your comments
could include any of the following: Research opportunities for the
themes highlighted above; innovative strategies to advance research
progress; the challenges to progress in these areas; emerging trends,
advances, technologies, analytic strategies, challenges in big data
science, and perspectives that NIDDK should consider in this planning
process; potential approaches to gauge research progress and success.
Please also comment on any other topic that you find relevant to the
development of the NIDDK Institute-wide Strategic Plan.
Organizations are strongly encouraged to submit a single response
that reflects the views of their organization and membership as a
whole.
Responses to this RFI are voluntary and may be submitted
anonymously. Please do not include any information that you do not wish
to make public. Proprietary, classified, confidential, or sensitive
information should not be included in your response. The Government
will use the information submitted in response to this RFI at its
discretion. Individual feedback will not be provided to any responder.
The Government reserves the right to use any submitted information on
public websites, in reports, in summaries of the state of the science,
in any possible resultant solicitation(s), grant(s), or cooperative
agreement(s), or in the development of future funding opportunity
announcements. This RFI is for informational and planning purposes only
and is not a solicitation for applications or an obligation on the part
of the Government to provide support for any ideas identified in
response to it. Please note that the Government will not pay for the
preparation of any information submitted or for use of that
information.
NIDDK looks forward to your input and we hope that you will share
this RFI with your colleagues.
Dated: March 20, 2020.
Bruce T. Roberts,
Health Science Policy Analyst, National Institute of Diabetes and
Digestive and Kidney Diseases.
[FR Doc. 2020-06271 Filed 3-25-20; 8:45 am]
BILLING CODE 4140-01-P